We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FIBI:TASEFirst International Bank of Israel Ltd Analysis

Data as of 2026-03-15 - not real-time

ILA 33,320.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The stock is trading comfortably above its short‑term and mid‑term moving averages, reinforcing the identified bullish price direction. Momentum indicators show a neutral reading, with the relative strength index hovering around the midpoint, suggesting neither overbought nor oversold conditions. The MACD histogram is negative, indicating recent bearish momentum that could temper short‑term upside. Trading volume has been on an upward trajectory, supporting the price advance and enhancing liquidity. The beta reading is notably low, implying that the share price is less volatile than the broader market, while the 30‑day volatility metric remains elevated, pointing to larger price swings.
Valuation metrics show a price‑to‑earnings multiple well below the sector average, hinting at a potential undervaluation relative to peers. Conversely, the price‑to‑book ratio is exceptionally high, which tempers the optimism from the earnings multiple. The dividend yield is attractive and the payout ratio sits comfortably below the fifty‑percent threshold, supporting the view that the dividend is sustainable. With strong cash reserves offset by negative operating cash flow, the balance sheet is mixed, adding a layer of caution. Overall, the combination of a solid dividend, modest valuation on earnings, and low market correlation makes the stock appealing for income‑focused investors, while the elevated volatility and high book valuation suggest a measured approach.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price above short‑term moving averages
  • negative MACD histogram
  • increasing trading volume

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • PE below industry average
  • high dividend yield with sustainable payout
  • low beta indicating defensive profile

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • strong dividend income
  • low market correlation
  • high price‑to‑book ratio raising valuation concerns

Key Metrics & Analysis

Financial Health

Revenue Growth0.90%
Profit Margin15.95%
P/E Ratio11.1
ROE16.78%
ROA0.95%
P/B Ratio167.9
Op. Cash FlowILA-1027000000
Industry P/E16.4

Technical Analysis

TrendBullish
RSI51.1
SupportILA 32,090.00
ResistanceILA 37,420.00
MA 20ILA 34,391.00
MA 50ILA 31,246.80
MA 200ILA 25,888.45
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

GradeUndervalued
TypeValue
Dividend Yield7.11%

Risk Assessment

Beta0.17
Volatility57.97%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.